Paradigm

Paradigm is Now Part of Exact Sciences

Exact Sciences and Paradigm have teamed up to take on cancer, together. By combining our leading portfolio of products, we're helping people make the most challenging decisions with confidence, providing earlier answers and life-changing treatment guidance.

The Paradigm PCDx Test is now the Oncotype MAP Pan-Cancer Tissue test for patients with advanced cancer.

If you would like to access your PCDx results, you can still access the Paradigm Portal